|

Single dose injection of certain dose of UWD-19 Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Wondercel Biotech (ShenZhen)1

Indications

  • B-Cell Leukemia1
  • B-cell Malignancy1
  • B Cell Lymphoma1
  • Cancer1

Other1 trial

Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.